Quick Summary — IRWD scores higher on quality with 7.7/10 vs KMDA's 1.9/10. IRWD trades at $3.28 while KMDA trades at $7.51. Both analyzed daily using SEC EDGAR data across 13 institutional models.
IRWD scores higher with a 7.7/10 quality rating vs KMDA's 1.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.
IRWD currently trades at $3.28 while KMDA trades at $7.51. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily for both companies.
IRWD earns a Quality of Company score of 7.7/10 compared to KMDA's 1.9/10. This is a significant quality gap — the higher-scoring company demonstrates materially stronger fundamentals across profitability, growth consistency, and balance sheet health. The QOC score synthesizes 32 signals spanning profitability margins, revenue growth, free cash flow, capital allocation, and leverage.
Review the value trap analysis for both IRWD and KMDA to assess whether apparent undervaluation reflects genuine opportunity or hidden fundamental risk.
Both IRWD and KMDA operate in Drug Manufacturers - Specialty & Generic, which has 79 stocks tracked by CirclFi. Same-industry comparisons provide the most direct insight into relative valuation since both companies face similar regulatory environments, market dynamics, and competitive pressures. Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN), and ensemble methods (CUCE).
11 hidden models compare IRWD vs KMDA differently — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more. Some may disagree with the 2 you see above.
Bloomberg Terminal: ~$2,000/mo · FactSet: ~$1,000/mo · CirclFi: $0.90/day
See All 13 Models — $0.90/dayWe don’t predict prices. We show you what 13 independent mathematical frameworks say a stock is worth — and let you decide.